Iambic Therapeutics

📍 San Diego, United States🗓 Founded 2020👥 131 employees💰 Last funded Oct 2024
Biotechnology Research🌐 iambic.ai
Website LinkedIn
Iambic is a clinical-stage AI biotech developing novel medicines using its AI-driven platform. Based in San Diego and founded in 2020, Iambic has assembled a world-class team that unites pioneering AI experts and experienced drug hunters. The Iambic platform has demonstrated delivery of new drug candidates to human clinical trials with industry-leading speed and across multiple target classes and mechanisms of action. Iambic is advancing a pipeline of potential best-in-class and first-in-class clinical assets to address urgent unmet patient need. Learn more at iambic.ai
6
Total investors
1
Early stage
5
Mid stage
0
Late stage
2020
Founded

Investors

6 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
6
Investor activity2020–2024 · investors recorded per year
202012023320242
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Iambic Therapeutics?
Iambic Therapeutics has 6 investors on record on gritt.io, including 1 early-stage backers, 5 mid-stage.
When did Iambic Therapeutics last raise funding?
The most recent investment in Iambic Therapeutics recorded on gritt.io was in October 2024.
When was Iambic Therapeutics founded?
Iambic Therapeutics was founded in 2020.
What industry is Iambic Therapeutics in?
Iambic Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Iambic Therapeutics based?
Iambic Therapeutics is headquartered in San Diego, United States.